uterine cancer (Cancer)
Information
- Disease name
- uterine cancer
- Disease ID
- DOID:363
- Description
- "A female reproductive organ cancer that is located_in the uterus." [url:http\://www.cancer.gov/dictionary?CdrID=445094]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT03934827 | Active, not recruiting | Phase 1 | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour | April 10, 2019 | December 31, 2022 |
NCT04383210 | Active, not recruiting | Phase 2 | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | September 29, 2020 | March 2025 |
NCT03668340 | Active, not recruiting | Phase 2 | AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma | October 22, 2018 | December 31, 2025 |
NCT04398446 | Active, not recruiting | Phase 2 | Effect of Hemp-CBD on Patients With CIPN | May 27, 2020 | April 1, 2023 |
NCT05939440 | Active, not recruiting | N/A | Interventions to Decrease Financial Toxicity | June 1, 2022 | May 26, 2025 |
NCT04681248 | Available | Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors | |||
NCT06401265 | Completed | Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC) | January 1, 2018 | September 5, 2022 | |
NCT00508703 | Completed | Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | March 5, 2003 | September 8, 2017 | |
NCT00581646 | Completed | Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance | September 2006 | June 2015 | |
NCT00584857 | Completed | Phase 2 | A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer | July 2004 | October 2011 |
NCT00588276 | Completed | Phase 1 | Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors | June 2005 | June 2012 |
NCT00588640 | Completed | Phase 1/Phase 2 | Study of D-Methadone in Patients With Chronic Pain | October 2004 | July 2008 |
NCT00614835 | Completed | N/A | Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus | August 2001 | January 2012 |
NCT05529303 | Completed | N/A | Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients | February 26, 2023 | September 18, 2023 |
NCT00706875 | Completed | A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors | June 2008 | April 2018 | |
NCT00746018 | Completed | N/A | Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy | August 2008 | July 2017 |
NCT00870233 | Completed | Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life | March 24, 2009 | February 12, 2018 | |
NCT00944944 | Completed | Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema | July 2009 | January 2010 | |
NCT01163552 | Completed | Phase 2 | Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity | June 2010 | May 2014 |
NCT04604158 | Completed | N/A | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients | December 2, 2020 | May 17, 2024 |
NCT04492007 | Completed | N/A | Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS) | November 2, 2020 | December 20, 2021 |
NCT01370122 | Completed | Pelvic Floor Disorders in Survivors of Gynecologic Malignancies | May 2011 | September 2017 | |
NCT01399658 | Completed | Phase 2 | Image-Guided Gynecologic Brachytherapy | September 2011 | June 2016 |
NCT01432015 | Completed | Phase 4 | Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting | September 2011 | March 2015 |
NCT01492179 | Completed | Phase 4 | Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. | November 2011 | June 2013 |
NCT01570218 | Completed | N/A | Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy | February 2010 | February 2011 |
NCT00231868 | Completed | Phase 2 | A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma | December 2001 | July 2011 |
NCT03701529 | Completed | N/A | Effect of Anesthetic Agents on Optic Nerve Sheath Diameter | October 15, 2018 | September 16, 2019 |
NCT03604653 | Completed | Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers | May 15, 2018 | May 1, 2021 | |
NCT03662204 | Completed | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | August 23, 2018 | March 31, 2022 | |
NCT00284427 | Completed | Phase 2 | Safety of Antioxidants During GYN Cancer Care | September 2005 | December 2006 |
NCT00444054 | Completed | N/A | The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer | February 2006 | May 2012 |
NCT03241745 | Completed | Phase 2 | A Study of Nivolumab in Selected Uterine Cancer Patients | August 3, 2017 | April 1, 2024 |
NCT03285802 | Completed | Phase 2/Phase 3 | Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation | September 7, 2017 | February 12, 2019 |
NCT03395080 | Completed | Phase 2 | A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma | March 5, 2018 | January 27, 2021 |
NCT00275353 | Completed | Phase 2 | Effectiveness of an Individualized Symptom Education Program (ISEP) | July 2003 | February 2006 |
NCT01601548 | Completed | N/A | Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy | July 2012 | July 2013 |
NCT01709175 | Completed | N/A | Strength Training Study for Survivors of Breast and Gynecologic Cancer | November 2012 | January 2015 |
NCT01870947 | Completed | N/A | Assisted Exercise in Obese Endometrial Cancer Patients | September 7, 2011 | September 4, 2019 |
NCT01953107 | Completed | Phase 4 | Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. | November 2013 | December 2020 |
NCT01962272 | Completed | Phase 4 | The Effect of Nutritional Counseling for Cancer Patients | January 2010 | September 2010 |
NCT02069769 | Completed | N/A | Ensuring Communication in Hospice by Oncology Study (ECHO) | January 2014 | January 2017 |
NCT04363957 | Completed | N/A | Evaluation of Patient Reported Knowledge and Satisfaction Following the Use of an Enhanced Gynecologic Brachytherapy-Specific Educational Video | April 1, 2020 | April 22, 2022 |
NCT02209532 | Completed | N/A | A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping | December 2015 | June 2017 |
NCT04262089 | Completed | Phase 1 | Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study | November 1, 2020 | November 1, 2023 |
NCT04068675 | Completed | N/A | Effects of Centering Pre-operative Counseling on Patient Reported Anxiety | February 24, 2020 | June 30, 2021 |
NCT02465892 | Completed | N/A | Pillars4Life Trial | May 2015 | October 2016 |
NCT02531997 | Completed | N/A | A Mind-body Intervention to Improve Body and/or Self Image | August 2015 | December 2017 |
NCT02714621 | Completed | N/A | MR-HIFU for Recurrent Gynaecological Cancer | May 2016 | March 31, 2020 |
NCT02725489 | Completed | Phase 2 | Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers | June 3, 2016 | December 2, 2020 |
NCT02896413 | Completed | N/A | The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection | June 2, 2016 | October 24, 2018 |
NCT00147680 | Completed | Phase 2 | Uterine Papillary Serous Cancer (UPSC) Trial | September 2004 | October 2009 |
NCT00231842 | Completed | Phase 2 | Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus | February 2003 | July 2011 |
NCT03813719 | Completed | Anxiety and Distress Levels in Women With Suspected Endometrial Cancer | July 1, 2018 | August 1, 2019 | |
NCT03073525 | Completed | Phase 2 | A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers | May 31, 2017 | May 18, 2022 |
NCT03192059 | Completed | Phase 2 | Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer | July 1, 2017 | June 30, 2021 |
NCT03762733 | Enrolling by invitation | Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies | January 4, 2022 | December 29, 2028 | |
NCT05998811 | Not yet recruiting | Insights Into Participating in Studies for Uterine Cancer | September 2024 | September 2026 | |
NCT06369155 | Not yet recruiting | Phase 2 | Azenosertib in Uterine Serous Carcinoma: Biomarker Study | September 2024 | January 31, 2027 |
NCT06392997 | Not yet recruiting | Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology | June 2024 | June 2026 | |
NCT06447064 | Recruiting | Cancer Loyalty Card Study 2 (CLOCS-2) | April 29, 2024 | March 31, 2027 | |
NCT02986568 | Recruiting | N/A | Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers | May 10, 2016 | December 31, 2025 |
NCT02993900 | Recruiting | N/A | Image-Guided Gynecologic Brachytherapy | December 15, 2016 | December 2028 |
NCT03476681 | Recruiting | Phase 1/Phase 2 | Study of NEO-201 in Solid Tumors Expansion Cohorts | January 18, 2019 | October 15, 2026 |
NCT03556228 | Recruiting | Phase 1 | Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma | June 8, 2018 | June 2026 |
NCT03702309 | Recruiting | Liquid Biopsy Evaluation and Repository Development at Princess Margaret | August 3, 2017 | July 6, 2024 | |
NCT03924466 | Recruiting | Phase 2 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients | April 1, 2019 | December 2024 |
NCT04028479 | Recruiting | The Registry of Oncology Outcomes Associated With Testing and Treatment | May 5, 2021 | October 1, 2031 | |
NCT04038619 | Recruiting | Phase 1 | Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients | February 1, 2021 | December 31, 2025 |
NCT05220033 | Recruiting | N/A | Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer | July 14, 2020 | December 1, 2025 |
NCT05344950 | Recruiting | Connecting Audio and Radio Sensing Systems to Improve Care at Home | March 21, 2022 | July 2025 | |
NCT05559879 | Recruiting | Phase 1/Phase 2 | Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma | August 20, 2023 | December 2025 |
NCT05697198 | Recruiting | PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine | April 19, 2021 | September 2024 | |
NCT05708950 | Recruiting | Phase 1/Phase 2 | A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) | March 3, 2023 | December 31, 2024 |
NCT05738902 | Recruiting | Adherence and Compliance to ERAS in Gynecological Surgery | May 30, 2023 | March 31, 2025 | |
NCT05743517 | Recruiting | N/A | Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) | September 15, 2023 | August 1, 2029 |
NCT05758688 | Recruiting | N/A | Whole Pelvis Proton Radiation for Gynecologic Cancer | November 6, 2023 | March 2026 |
NCT05864144 | Recruiting | Phase 1/Phase 2 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | May 31, 2023 | June 2027 |
NCT05916196 | Recruiting | Phase 2 | [18F]FES PET/.CT in Uterine Cancer | September 1, 2023 | August 1, 2026 |
NCT05976113 | Recruiting | A Retrospective Study on Multiple Classifier Endometrial Cancer | July 27, 2023 | August 31, 2023 | |
NCT05977621 | Recruiting | Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking | February 7, 2024 | February 2025 | |
NCT05990426 | Recruiting | N/A | Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy | October 16, 2023 | August 2026 |
NCT06024109 | Recruiting | Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy | March 19, 2024 | January 2026 | |
NCT06203106 | Recruiting | NYSCF Scientific Discovery Biobank | November 10, 2022 | November 10, 2045 | |
NCT03842865 | Temporarily not available | Expanded Access of Vigil in Solid Tumors | |||
NCT01010334 | Terminated | N/A | Comparison of Standard of Care or Treatment on Protocol | March 2009 | July 2011 |
NCT01284075 | Terminated | N/A | The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery | April 2010 | April 2013 |
NCT00582205 | Terminated | Phase 2 | Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma | January 2006 | December 2011 |
NCT00506779 | Terminated | Phase 1/Phase 2 | Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma | December 29, 2003 | April 2015 |
NCT00626561 | Terminated | Phase 2 | Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix | February 2008 | July 2011 |
NCT03694834 | Terminated | Early Phase 1 | Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer | March 29, 2019 | October 23, 2023 |
NCT00584909 | Terminated | Phase 2 | A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus | March 2006 | September 2011 |
NCT03423082 | Terminated | Phase 4 | Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer. | December 11, 2018 | December 18, 2019 |
NCT00471120 | Terminated | N/A | Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer | November 2006 | February 2008 |
NCT00231829 | Terminated | Phase 2 | A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers | April 2003 | March 2004 |
NCT04424641 | Terminated | Phase 1/Phase 2 | A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors | July 15, 2020 | October 29, 2021 |
NCT03021200 | Unknown status | N/A | Laser Fluorescence in Cancer Surgical Treatment | July 12, 2016 | December 10, 2020 |
NCT03896958 | Unknown status | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | March 21, 2019 | March 12, 2024 | |
NCT01650376 | Unknown status | Phase 1/Phase 2 | Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer | August 2012 | December 2019 |
NCT02952183 | Unknown status | N/A | Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors | July 2015 | |
NCT04849858 | Unknown status | Phase 3 | Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures | May 20, 2019 | June 2022 |
NCT01600040 | Unknown status | N/A | Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix | May 2013 | September 2023 |
NCT02458001 | Unknown status | N/A | Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer | July 2015 | March 2017 |
NCT04239443 | Unknown status | Phase 2 | Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer | January 30, 2019 | March 31, 2022 |
NCT02349958 | Unknown status | Phase 2 | Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy | September 2006 | January 2022 |
NCT00588263 | Withdrawn | Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer | July 2000 | July 2018 | |
NCT01176500 | Withdrawn | Phase 1/Phase 2 | A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors | July 28, 2010 | November 18, 2011 |
NCT03583736 | Withdrawn | N/A | Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer | June 27, 2018 | June 1, 2020 |
NCT02095847 | Withdrawn | Phase 2 | High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection | March 2015 | |
NCT04368130 | Withdrawn | N/A | SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care | September 1, 2022 | September 1, 2023 |
- Disase is a (Disease Ontology)
- DOID:120
- Cross Reference ID (Disease Ontology)
- ICD10CM:C55
- Cross Reference ID (Disease Ontology)
- ICD9CM:179
- Cross Reference ID (Disease Ontology)
- MESH:D014594
- Cross Reference ID (Disease Ontology)
- NCI:C3435
- Cross Reference ID (Disease Ontology)
- NCI:C3552
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:126908007
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:371973000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0042138
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153567
- Exact Synonym (Disease Ontology)
- CA - cancer of uterus
- Exact Synonym (Disease Ontology)
- malignant neoplasm of uterus
- Exact Synonym (Disease Ontology)
- malignant uterine tumor
- Exact Synonym (Disease Ontology)
- neoplasm of uterus
- Exact Synonym (Disease Ontology)
- Tumour of uterus
- Exact Synonym (Disease Ontology)
- uterine tumor
- Exact Synonym (Disease Ontology)
- uterus neoplasm